The novel PROMISE framework for PSMA-PET reporting: ready for the clinical routine?

被引：1
|
作者：
Seifert, Robert [1 ,2 ]
Eiber, Matthias [3 ,4 ]
Herrmann, Ken [1 ,2 ]
Hadaschik, Boris [2 ,5 ]
Fendler, Wolfgang Peter [1 ,2 ,6 ]
机构：
[1] Univ Duisburg Essen, Dept Nucl Med, Hufelandstr 55, D-45147 Essen, Germany
[2] Univ Hosp Essen, German Canc Consortium DKTK, Hufelandstr 55, D-45147 Essen, Germany
[3] Tech Univ Munich, Dept Nucl Med, Klinikum Rechts Isar, Munich, Germany
[4] Bavarian Canc Res Ctr BZKF, Munich, Germany
[5] Univ Duisburg Essen, Dept Urol, Essen, Germany
[6] German Soc Nucl Med, PET Comm, Gottingen, Germany
来源：
CLINICAL AND TRANSLATIONAL IMAGING | 2024年 / 12卷 / 01期
关键词：
D O I：
10.1007/s40336-023-00596-y
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [21] Relating proton LETd to biological response of salivary glands using PSMA-PET in clinical patients
    Wagenaar, D.
    Langendijk, J.
    Mohan, V.
    Steenbakkers, R.
    Vogel, W.
    Both, S.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1523 - S1524
  • [22] Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study
    Karpinski, Madeleine J.
    Huesing, Johannes
    Claassen, Kevin
    Moeller, Lennart
    Kajueter, Hiltraud
    Oesterling, Florian
    Gruenwald, Viktor
    Umutlu, Lale
    Kleesiek, Jens
    Telli, Tugce
    Merkel-Jens, Anja
    Huesing, Anika
    Kesch, Claudia
    Herrmann, Ken
    Eiber, Matthias
    Hoberueck, Sebastian
    Meyer, Philipp
    Kind, Felix
    Rahbar, Kambiz
    Schaefers, Michael
    Stang, Andreas
    Hadaschik, Boris A.
    Fendler, Wolfgang P.
    LANCET ONCOLOGY, 2024, 25 (09): : 1188 - 1201
  • [23] Radiotherapy for node-positive prostate cancer in the PSMA-PET era: The need for prospective clinical trials
    Ong, Wee Loon
    Kang, Therese Min Jung
    Loblaw, Andrew
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2025, 69 (01) : 126 - 128
  • [24] Relating proton LETd to biological response of parotid and submandibular glands using PSMA-PET in clinical patients
    Wagenaar, Dirk
    Mohan, Vineet
    Langendijk, Johannes A.
    Steenbakkers, Roel J. H. M.
    Vogel, Wouter V.
    Both, Stefan
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2025, 52
  • [25] Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT
    Mihatsch, Patrick W.
    Beissert, Matthias
    Pomper, Martin G.
    Bley, Thorsten A.
    Seitz, Anna K.
    Kuebler, Hubert
    Buck, Andreas K.
    Rowe, Steven P.
    Serfling, Sebastian E.
    Hartrampf, Philipp E.
    Werner, Rudolf A.
    CANCERS, 2022, 14 (02)
  • [26] Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): An international multicenter study
    Gafita, A.
    Rauscher, I
    Weber, M. E.
    Hadaschik, B.
    Wang, H.
    Armstrong, W. R.
    Tauber, R.
    Grogan, T. R.
    Czernin, J.
    Rettig, M. B.
    Herrmann, K.
    Calais, J.
    Weber, W.
    Benz, M. R.
    Fendler, W. P. W.
    Eiber, M.
    EUROPEAN UROLOGY, 2022, 81 : S794 - S795
  • [27] PROMISE criteria in practice-The predictive value of prebiopsy PSMA-PET/CT in PET/CT-Ultrasound fusion guided prostate biopsy for men with previous negative biopsies
    Liu, Chen
    Liu, Teli
    Zhang, Zhongyi
    Zhang, Ning
    Du, Peng
    Yang, Yong
    Liu, Yiqiang
    Wang, Jing
    Yu, Wei
    Li, Nan
    Zhu, Hua
    Yan, Kun
    Yang, Zhi
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [28] Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0):an international multicenter study
    Gafita, A.
    Rauscher, I.
    Weber, M.
    Hadaschik, B.
    Wang, H.
    Armstrong, W.
    Tauber, R.
    Grogan, T.
    Czernin, J.
    Rettig, M.
    Herrmann, K.
    Calais, J.
    Weber, W.
    Benz, M.
    Fendler, W.
    Eiber, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S269 - S269
  • [29] Development of a novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP): an international multicenter study
    Gafita, A.
    Rauscher, I.
    Weber, M.
    Hadaschik, B.
    Wang, H.
    Armstrong, W. R.
    Tauber, R.
    Grogan, T. R.
    Czernin, J.
    Rettig, M. B.
    Herrmann, K.
    Calais, J.
    Weber, W. A.
    Benz, M. R.
    Fendler, W. P.
    Eiber, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S311 - S312
  • [30] Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP): An international multicenter study.
    Gafita, Andrei
    Rauscher, Isabel
    Weber, Manuel
    Hadaschik, Boris A.
    Wang, Hui
    Armstrong, Wesley R.
    Tauber, Robert
    Grogan, Tristan
    Czernin, Johannes
    Rettig, Matthew
    Herrmann, Ken
    Calais, Jeremie
    Weber, Wolfgang A.
    Benz, Matthias R.
    Fendler, Wolfgang Peter
    Eiber, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
12345